Johnson & Johnson (JNJ) Exec Will Become Boston Scientific Corporation (BSX) CEO  
9/14/2011 7:00:41 AM

Boston Scientific Corp (NYSE:BSX - News) named Johnson & Johnson (NYSE:JNJ - News) executive Michael Mahoney as its new president and chief executive, replacing Ray Elliott, who announced in May he intended to step down. Mahoney, 46, who has served as chairman of J&J's medical device and diagnostics business, will become Boston Scientific's president on October 17 and is expected to become CEO next year on Nov 1, 2012, to accommodate post-employment obligations with J&J, Boston Scientific said.